Bromide

Bromide

SCHEMBL1252844

C=CC(=O)OCCC[N+](C)(C)C.[Br-]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 known ✓ P08912 4/20 0.41
CHRM1 known ✓ P11229 4/20 0.41
CHRM3 known ✓ P20309 4/20 0.41
CHRM2 known ✓ P08172 3/20 0.41
CHRM4 known ✓ P08173 3/20 0.41
ACHE known ✓ P22303 1/20 0.38
TSHR P16473 8/20 0.61
ALDH1A1 P00352 3/20 0.61
CYP3A4 P08684 1/20 0.61
HPGD P15428 1/20 0.60
TP53 P04637 2/20 0.50
HIF1A Q16665 2/20 0.50
HSD17B10 Q99714 1/20 0.50
GALR3 O60755 1/20 0.44
GAA P10253 1/20 0.44
RAB9A P51151 1/20 0.44
THRB P10828 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
HTR1A P08908 2/20 0.41
CHRNB2 P17787 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1477274 0.98 TSHR (0.63) TSHRALDH1A1CYP3A4HPGDTP53
Fluoride Ion SCHEMBL1254984 0.96 TSHR (0.61) TSHRALDH1A1CYP3A4HPGDTP53
Hydrochloric Acid SCHEMBL129464 0.96 TSHR (0.61) TSHRALDH1A1CYP3A4HPGDTP53
Water SCHEMBL31228290 0.96 TSHR (0.61) TSHRALDH1A1CYP3A4HPGDTP53
Iodide SCHEMBL1254266 0.96 TSHR (0.61) TSHRALDH1A1CYP3A4HPGDTP53
Chloromethane SCHEMBL27843306 0.94 TSHR (0.59) TSHRALDH1A1CYP3A4HPGDTP53
Hydrochloric Acid SCHEMBL27418780 0.94 TSHR (0.59) TSHRALDH1A1CYP3A4HPGDTP53
Bromide SCHEMBL1255030 0.94 TSHR (0.64) TSHRALDH1A1CYP3A4HPGDTP53
Bromide SCHEMBL2948068 0.93 TSHR (0.68) TSHRALDH1A1CYP3A4HPGDTP53
Bromide SCHEMBL28987029 0.93 TSHR (0.68) TSHRALDH1A1CYP3A4HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024254965-A1 POLYELECTROLYTE GEL, PREPARATION METHOD THEREFOR AND USE THEREOF 清华大学 2024-12-19 WO claimed
CN-117024774-A Polyelectrolyte gel, preparation method and application thereof 清华大学 2023-11-10 CN claimed
US-12570860-B2 Two-component treatment agent, treatment method for making metal surface antibacterial and antibacterial treatment agent TOKYO OHKA KOGYO CO., LTD. (JP) 2026-03-10 US disclosed
EP-3892612-B1 METHOD FOR PRODUCING ORGANIC TELLURIUM COMPOUND AND METHOD FOR PRODUCING VINYL POLYMER OTSUKA CHEMICAL CO LTD (JP) 2025-05-14 EP disclosed
WO-2024254965-A1 POLYELECTROLYTE GEL, PREPARATION METHOD THEREFOR AND USE THEREOF 清华大学 2024-12-19 WO disclosed
CN-117586645-A Coloring composition containing dioxazine pigment and color filter 大塚化学株式会社 2024-02-23 CN disclosed
CN-117024774-A Polyelectrolyte gel, preparation method and application thereof 清华大学 2023-11-10 CN disclosed
US-11713294-B2 Method for producing organic tellurium compound and method for producing vinyl polymer OTSUKA CHEMICAL CO., LTD (JP) 2023-08-01 US disclosed
CN-113166050-B Method for producing organotellurium compound and method for producing vinyl polymer 大塚化学株式会社 2023-04-18 CN disclosed
US-20220267615-A1 TWO-COMPONENT TREATMENT AGENT, TREATMENT METHOD FOR MAKING METAL SURFACE ANTIBACTERIAL AND ANTIBACTERIAL TREATMENT AGENT TOKYO OHKA KOGYO CO., LTD. (JP) 2022-08-25 US disclosed
CN-111971116-B Dispersant composition, coloring composition and color filter 大塚化学株式会社 2022-06-28 CN disclosed
US-8461237-B2 Gel composition, method of preparing the same, and impact resistant absorbing material using the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-06-11 US disclosed
EP-2387866-A1 ELECTROMAGNETIC WAVE SHIELDING GEL-LIKE COMPOSITION 3M Innovative Properties Company (US) 2011-11-23 EP disclosed
US-20110268950-A1 Electromagnetic Wave Shielding Gel-Like Composition 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-11-03 US disclosed
US-8038066-B2 Laser scanner with deformable lens HAND HELD PRODUCTS, INC. (US) 2011-10-18 US disclosed
US-20110097585-A1 GEL COMPOSITION, METHOD OF PREPARING THE SAME, AND IMPACT RESISTANT ABSORBING MATERIAL USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2011-04-28 US disclosed
EP-2285900-A2 GEL COMPOSITION, METHOD FOR PREPARING THE SAME, AND IMPACT RESISTANT ABSORBING MATERIAL USING THE SAME 3M Innovative Properties Company (US) 2011-02-23 EP disclosed
WO-2010083075-A1 ELECTROMAGNETIC WAVE SHIELDING GEL-LIKE COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-07-22 WO disclosed
US-20100173104-A1 MANUFACTURING METHOD OF RECORDING MEDIUM, INKJET RECORDING MEDIUM, AND METHOD OF MANUFACTURING THE SAME FUJIFILM CORPORATION (JP) 2010-07-08 US disclosed
WO-2009134694-A2 GEL COMPOSITION, METHOD FOR PREPARING THE SAME, AND IMPACT RESISTANT ABSORBING MATERIAL USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-11-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713294-B2 Method for producing organic tellurium compound and method for producing vinyl polymer TERB1, EMG1, ME1 CHRM5 167/4885CHRM1 27/4885CHRM3 687/4885
US-12570860-B2 Two-component treatment agent, treatment method for making metal surface antibacterial and antibacterial treatment agent SARS1, ACE2, EIF2AK2 CHRM5 3874/4885CHRM1 2671/4885CHRM3 3038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.